Franz J Gildehaus
Overview
Explore the profile of Franz J Gildehaus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
481
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eismann L, Ledderose S, Enzinger B, Berg E, Westhofen T, Rodler S, et al.
Eur J Nucl Med Mol Imaging
. 2024 May;
51(11):3461-3464.
PMID: 38761187
Purpose: Penile cancer is a rare entity and has a good prognosis in localized stage. Delayed surgical treatment of lymphatic disease is associated with poor overall survival but conventional imaging...
2.
Unterrainer L, Beyer L, Zacherl M, Gildehaus F, Todica A, Kunte S, et al.
Biomedicines
. 2022 May;
10(5).
PMID: 35625683
Background: PSMA-based alpha therapy using 225Ac-PSMA-I&T provides treatment for metastatic castration-resistant prostate cancer (mCRPC), even after the failure of 177Lu-PSMA radioligand therapy (RLT). In clinical routine, the total tumor volume...
3.
Unterrainer M, Lindner S, Beyer L, Gildehaus F, Todica A, Mittlmeier L, et al.
Clin Nucl Med
. 2021 Mar;
46(8):667-668.
PMID: 33782306
PET using 68Ga-labeled somatostatin receptor (SSTR) ligands adds significant information in meningioma patients. 18F-SiTATE is a novel, 18F-labeled SSTR-targeting peptide with remarkable imaging properties. Here, we present a 72-year-old woman...
4.
Fendler W, Reinhardt S, Ilhan H, Delker A, Boning G, Gildehaus F, et al.
Oncotarget
. 2016 Sep;
8(2):3581-3590.
PMID: 27683041
Prostate cancer can be targeted by ligands to the prostate-specific membrane antigen (PSMA). We aimed to evaluate dosimetry, safety and efficacy of 177Lu-PSMA-617 radioligand therapy (RLT) in patients with metastatic...
5.
Ilhan H, Wang H, Gildehaus F, Wangler C, Herrler T, Todica A, et al.
EJNMMI Res
. 2016 Aug;
6(1):64.
PMID: 27515447
Background: Radiation-induced nephropathy is still dose limiting in radionuclide therapy of neuroendocrine tumors. We investigated the nephroprotective potential of the angiotensine converting enzyme inhibiting drug enalpril after [177Lu]-DOTATATE therapy in...
6.
Holzgreve A, Brendel M, Gu S, Carlsen J, Mille E, Boning G, et al.
Front Neurosci
. 2016 Jul;
10:260.
PMID: 27378835
Noninvasive tumor growth monitoring is of particular interest for the evaluation of experimental glioma therapies. This study investigates the potential of positron emission tomography (PET) using O-(2-(18)F-fluoroethyl)-L-tyrosine ([(18)F]-FET) to determine...
7.
Fendler W, Schmidt D, Wenter V, Thierfelder K, Zach C, Stief C, et al.
J Nucl Med
. 2016 Jun;
57(11):1720-1725.
PMID: 27261520
Methods: Twenty-one patients with biopsy-proven prostate cancer underwent Ga-PSMA-HBED-CC (Ga-PSMA) PET/CT at a median of 4 d (range, 0-47 d) before radical prostatectomy. Based on a 6-segment model, the Gleason...
8.
Andrukhova O, Salama M, Krssak M, Wiedemann D, El-Housseiny L, Hacker M, et al.
J Card Fail
. 2014 Jan;
20(2):135-45.
PMID: 24412522
Background: Heart failure (HF) is a common and often fatal complication of myocardial infarction (MI). Glutathione S-transferase P1-1 (GSTP1) has antiapoptotic and antiinflammatory effects and is a specific serum marker...
9.
Klutz K, Schaffert D, Willhauck M, Grunwald G, Haase R, Wunderlich N, et al.
Mol Ther
. 2011 Jan;
19(4):676-85.
PMID: 21245850
We recently demonstrated tumor-selective iodide uptake and therapeutic efficacy of radioiodine in neuroblastoma tumors after systemic nonviral polyplex-mediated sodium iodide symporter (NIS) gene delivery. In the present study, we used...
10.
Popperl G, Kreth F, Mehrkens J, Herms J, Seelos K, Koch W, et al.
Eur J Nucl Med Mol Imaging
. 2007 Sep;
34(12):1933-42.
PMID: 17763848
Purpose: Treatment and prognosis of gliomas depend on their histological tumour grade. The aim of the study was to evaluate the potential of [(18)F]fluoroethyltyrosine (FET) PET for non-invasive tumour grading...